Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and macroalbuminuric diabetic nephropathy

Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and macroalbuminuric diabetic nephropathy - eGFR decline in biopsy-proven diabetic nephropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013409

Enrollment

100

Registered

2014-03-31

Start date

2014-03-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diabetes mellitus who underwent renal biopsy at our hospital and were confirmed to have diabetic nephropathy according to Tervaert's classification(J Am Soc Nephrol. 2010;21(4):556-63)

Exclusion criteria

Exclusion criteria: Transplanted kidney Coexistence of other renal diseases except for nephrosclerosis Type I diabetes normoalbuminuria or microalbuminuria eGFR <15 mL/min/1.73 m2 at baseline follow-up for less than 12 months except for commencement of dialysis within 12 months

Design outcomes

Primary

Measure	Time frame
Annual eGFR decline	—

Countries

Japan

Contacts

Public ContactKoki Mise

Toranomon Hospital Kajigaya Nephrology Center

kokims-frz@umin.ac.jp044-877-5111

Outcome results